MENU

Tel：029-82681864      Fax：029-82681864　

E-mail： gd_hipec@126.com 

Add:Building 1, Huoju Road, East zone of Xi’an

High-tech Development District, Xi’an, China

陕ICP备14004292号　Powered by www.300.cn

HOME
TEL
Message
更多
  • gd
  • gd
  • gd
  • gd
Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)
$strTool.escape($info.title)

Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy to Treat Gastric Cancer With Ascites andor Peritoneal Carcinomatosis Results From a Chinese Center
$strTool.escape($info.title)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy to Treat Gastric Cancer With Ascites andor Peritoneal Carcinomatosis Results From a Chinese Center

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients with Peritoneal Carcinomatosis from Abdominal and Pelvic Malignancies Results of 21 Cases
$strTool.escape($info.title)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients with Peritoneal Carcinomatosis from Abdominal and Pelvic Malignancies Results of 21 Cases

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer A Phase II Study from a Chinese Center
$strTool.escape($info.title)

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer A Phase II Study from a Chinese Center

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer Final Results of a Phase III Randomized Clinical Trial
$strTool.escape($info.title)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer Final Results of a Phase III Randomized Clinical Trial

Current status and future prospects of clinical trials on CRS  +  HIPEC for gastric cancer peritoneal metastases
$strTool.escape($info.title)

Current status and future prospects of clinical trials on CRS  +  HIPEC for gastric cancer peritoneal metastases

Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies
$strTool.escape($info.title)

Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies

Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)
$strTool.escape($info.title)

Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)

　　Lili Liu 1,Ning Zhang 1,Jie Min 1,Haichuan Su 1,Hongmei Wang 1,Dongxu Chen 1,Li

　　Sun 2,Hongwei Zhang 2,Wei Li 2,Helong Zhang 1

　　1 Department of Oncology,Tangdu Hospital,The Fourth Military Medic
The efficacy contrast observation of CCCHP and CHP in treatment of malignant effusion
$strTool.escape($info.title)

The efficacy contrast observation of CCCHP and CHP in treatment of malignant effusion

　　Jun Hu,Jun Chen,Wenjun Peng

　　Department of Oncology,Jiangxi Province Xingan County People's Hospital,Xingan County 331300,Jiangxi Province
Observation of the clinical treatment effect of body cavity circulative hyperthermic perfusion chemotherapy to treat malignant pleural effusion
$strTool.escape($info.title)

Observation of the clinical treatment effect of body cavity circulative hyperthermic perfusion chemotherapy to treat malignant pleural effusion

　　Chunmei Zhu,Li Liu.The Second People's Hospital of Tongling City,Tongling city,Anhui province 244000,China